AU2319392A - Cancer immunotherapy with antibodies to cancer procoagulant - Google Patents

Cancer immunotherapy with antibodies to cancer procoagulant

Info

Publication number
AU2319392A
AU2319392A AU23193/92A AU2319392A AU2319392A AU 2319392 A AU2319392 A AU 2319392A AU 23193/92 A AU23193/92 A AU 23193/92A AU 2319392 A AU2319392 A AU 2319392A AU 2319392 A AU2319392 A AU 2319392A
Authority
AU
Australia
Prior art keywords
cancer
antibodies
procoagulant
immunotherapy
cancer immunotherapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23193/92A
Inventor
Stuart G. Gordon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University Research Corp
Original Assignee
Univ Research Corp
University Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Research Corp, University Research Corp filed Critical Univ Research Corp
Publication of AU2319392A publication Critical patent/AU2319392A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6472—Cysteine endopeptidases (3.4.22)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU23193/92A 1992-07-07 1992-07-07 Cancer immunotherapy with antibodies to cancer procoagulant Abandoned AU2319392A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1992/005726 WO1994001536A1 (en) 1992-07-07 1992-07-07 Cancer immunotherapy with antibodies to cancer procoagulant

Publications (1)

Publication Number Publication Date
AU2319392A true AU2319392A (en) 1994-01-31

Family

ID=22231227

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23193/92A Abandoned AU2319392A (en) 1992-07-07 1992-07-07 Cancer immunotherapy with antibodies to cancer procoagulant

Country Status (2)

Country Link
AU (1) AU2319392A (en)
WO (1) WO1994001536A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6540693B2 (en) 1998-03-03 2003-04-01 Senorx, Inc. Methods and apparatus for securing medical instruments to desired locations in a patients body
US6344026B1 (en) 1998-04-08 2002-02-05 Senorx, Inc. Tissue specimen encapsulation device and method thereof
US6312429B1 (en) 1998-09-01 2001-11-06 Senorx, Inc. Electrosurgical lesion location device
US9408592B2 (en) 2003-12-23 2016-08-09 Senorx, Inc. Biopsy device with aperture orientation and improved tip
CN114062564B (en) * 2022-01-12 2022-04-12 北京第一生物化学药业有限公司 Detection method of taffeta and variants thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4461833A (en) * 1982-06-23 1984-07-24 University Patents, Inc. Chromatographically purifying proteolytic procoagulant enzyme from animal tissue extract
ATE76509T1 (en) * 1984-05-02 1992-06-15 Univ Research Corp IMMUNOLOGICAL TEST PROCEDURE OF A PROCOAGULATING ENZYME FOR THE DETECTION OF CANCER.
CA1307486C (en) * 1987-10-29 1992-09-15 Michael T. Largen Hybridoma production
US5212085A (en) * 1987-12-09 1993-05-18 The General Hospital Corporation Sf-25 colon adenocarcinoma antigen, and antibodies with recognize this antigen

Also Published As

Publication number Publication date
WO1994001536A1 (en) 1994-01-20

Similar Documents

Publication Publication Date Title
AU2100695A (en) Immunotherapy of cancer with allogeneic lymphocytes
AU5141193A (en) Monoclonal antibodies to prostate cells
AU589635B2 (en) Antibody conjugates
AU4231393A (en) Antibodies to leukemia inhibitory factor
AU625613B2 (en) Novel chimeric antibodies
AU5267190A (en) Modified antibodies
AU1480388A (en) Altered antibodies
AU4618193A (en) Humanized antibodies
AU4842993A (en) Composite back reflector for photovoltaic device
AU2514184A (en) Ornamental lighting device
AU590462B2 (en) Immunoglobulin conjugates
AU7334987A (en) Immunoglobulin conjugates
AU6080794A (en) Antibodies directed against binding-associated epitopes
AU5732694A (en) Humanized antibodies reactive with cd18
AU3330689A (en) Monoclonal antibodies
AU4450389A (en) Anti-fucosylcermiade monoclonal antibody
AU2319392A (en) Cancer immunotherapy with antibodies to cancer procoagulant
AU569816B2 (en) Monoclonal anti-alpha-amylase antibody
AU1288188A (en) Immunoglobulin conjugates
AU3752089A (en) Bispecific antibodies
AU4078089A (en) Decorative glass
AU2878989A (en) Antibody conjugates
GB2309459B (en) Antibodies to fungal antigens
AU1820692A (en) Novel anti-hiv antibodies
AU8547291A (en) Monoclonal antibodies against tenascin